FR2373517A1 - Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments - Google Patents

Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments

Info

Publication number
FR2373517A1
FR2373517A1 FR7736995A FR7736995A FR2373517A1 FR 2373517 A1 FR2373517 A1 FR 2373517A1 FR 7736995 A FR7736995 A FR 7736995A FR 7736995 A FR7736995 A FR 7736995A FR 2373517 A1 FR2373517 A1 FR 2373517A1
Authority
FR
France
Prior art keywords
radical
useful
active molecule
therapically
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736995A
Other languages
English (en)
Other versions
FR2373517B1 (fr
Inventor
Richard Rips
Elisabeth Morier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of FR2373517A1 publication Critical patent/FR2373517A1/fr
Application granted granted Critical
Publication of FR2373517B1 publication Critical patent/FR2373517B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des pseudopeptides. Pseudopeptide constitué par au moins un radical peptidique relié par une liaison peptide à au moins un radical correspondant à une molécule ou un dérivé d'une molécule thérapeutiquement active telle que l'amphétamine ou la dopamine ainsi que les sels, esters et amides correspondants Ces produits sont utiles comme médicaments.
FR7736995A 1976-12-10 1977-12-08 Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments Granted FR2373517A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51632/76A GB1592552A (en) 1976-12-10 1976-12-10 Pseudopeptides used as medicaments

Publications (2)

Publication Number Publication Date
FR2373517A1 true FR2373517A1 (fr) 1978-07-07
FR2373517B1 FR2373517B1 (fr) 1981-11-27

Family

ID=10460796

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736995A Granted FR2373517A1 (fr) 1976-12-10 1977-12-08 Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments

Country Status (5)

Country Link
US (1) US4297346A (fr)
CH (1) CH628324A5 (fr)
DE (1) DE2755036A1 (fr)
FR (1) FR2373517A1 (fr)
GB (1) GB1592552A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489320A1 (fr) * 1980-05-06 1982-03-05 Schally Andrew Nouveaux peptides anorexigenes
EP0099057A2 (fr) * 1982-07-14 1984-01-25 BASF Aktiengesellschaft Dérivés N-acylés de peptides, leur préparation et utilisation dans la lutte contre les maladies et moyen de lutte

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880781A (en) * 1984-08-06 1989-11-14 The Upjohn Company Renin inhibitory peptides containing an N-alkyl-histidine moiety
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
JP3350701B2 (ja) * 1991-05-23 2002-11-25 メレルダウファーマスーティカルズ インコーポレイテッド ボンベシン類似体類
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ATE228115T1 (de) * 1991-06-28 2002-12-15 Smithkline Beecham Corp Bizyklische fibrinogenantagonisten
CA2129032A1 (fr) * 1992-02-07 1993-08-19 Judson V. Edwards Analogues de la bombesine possedant des derives modifies de la phenylanine
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
US6737408B1 (en) * 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
GB0107924D0 (en) * 2001-03-29 2001-05-23 Angeletti P Ist Richerche Bio Inhibitor of hepatitis C virus NS3 protease
WO2003072046A2 (fr) * 2002-02-22 2003-09-04 New River Pharmaceuticals Inc. Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
WO2003018538A1 (fr) 2001-08-31 2003-03-06 Ajinomoto Co., Inc. Nouveaux derives de diarylalcene et nouveaux derives de diarylalcane
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
NZ544162A (en) * 2003-05-29 2008-09-26 Shire Llc Abuse resistant amphetamine compounds
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
US20070197445A1 (en) * 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
DK2560486T3 (en) 2010-04-21 2019-02-04 Signature Therapeutics Inc COMPOSITIONS COMPREHENSIVE ENZYM-TENDABLE AMPHETAMINE PRODRUGS AND ITS INHIBITORS
EP4198029A1 (fr) * 2015-08-17 2023-06-21 University Health Network Inhibiteurs d'enzymes peptidyl arginine désiminases (pad) et leurs utilisations
WO2019076675A1 (fr) * 2017-10-06 2019-04-25 Instituto De Medicina Molecular Traitement d'états liés à l'obésité

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4550M (fr) * 1964-09-15 1966-11-02
US3843447A (en) * 1972-09-22 1974-10-22 Syva Co Photolytically activated coupling to polypeptides
US3998799A (en) * 1973-11-02 1976-12-21 Interx Research Corporation Novel, transient pro-drug forms of l-dopa
US4064235A (en) * 1975-08-21 1977-12-20 Eisai Co., Ltd. Dopamine derivative compounds, preparation thereof and medicine containing same
US4043989A (en) * 1975-09-11 1977-08-23 Syva Company Oxazepam derivatives for immunoassay reagents
US4064236A (en) * 1975-12-23 1977-12-20 Merck & Co., Inc. Peptide carbazates and pharmaceutical composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1968 *
CA1974 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489320A1 (fr) * 1980-05-06 1982-03-05 Schally Andrew Nouveaux peptides anorexigenes
EP0099057A2 (fr) * 1982-07-14 1984-01-25 BASF Aktiengesellschaft Dérivés N-acylés de peptides, leur préparation et utilisation dans la lutte contre les maladies et moyen de lutte
EP0099057A3 (en) * 1982-07-14 1984-09-12 Basf Aktiengesellschaft N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor

Also Published As

Publication number Publication date
GB1592552A (en) 1981-07-08
CH628324A5 (fr) 1982-02-26
FR2373517B1 (fr) 1981-11-27
DE2755036A1 (de) 1978-06-15
US4297346A (en) 1981-10-27

Similar Documents

Publication Publication Date Title
FR2373517A1 (fr) Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
HU9401107D0 (en) Enhanced skin penetration system for improved topical delivery of drugs
NO306677B1 (no) Heterosykliske forbindelser, farmasöytiske preparater og anvendelse av en slik forbindelse til fremstilling av et medikament
MX9505182A (es) Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
NO306457B1 (no) 2,4-disulfonylfenylbutylnitron, salter derav, farmasöytisk sammensetning, samt anvendelse av denne forbindelse til fremstilling av et medikament
ATE196913T1 (de) Neuartige peptidderivate
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES2112874T3 (es) Utilizacion de acidos carboxilicos con contenido en azufre para combatir trastornos de excitacion de origen patofisiologico.
ES2173858T3 (es) Analogos de huperzina a.
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
ES2180564T3 (es) 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina.
GB1370973A (en) Therapeutic compositions
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
SE8904354D0 (sv) A pharmaceutical composition
NO940777L (no) Anvendelse av et pregnanderivat
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase

Legal Events

Date Code Title Description
ST Notification of lapse